Holen Sie sich die Stockscreener-App
30.50
2.96%
-0.93
Handel nachbörslich:
30.50
Sensei Biotherapeutics Inc Aktie (SNSE) Neueste Nachrichten
Fed Meeting: Whats next for CRWD stock2025 Market WrapUp & Accurate Entry/Exit Alerts - baoquankhu1.vn
Trails Edge Capital Partners, LP Acquires Shares in Sensei Bioth - GuruFocus
Revenue Check: Is Sensei Biotherapeutics Inc being accumulated by smart moneyWeekly Gains Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Sensei Biotherapeutics grants stock options to 17 new employees - Investing.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 25, 2026 - BioSpace
Sensei Biotherapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
SNSE (NASDAQ: SNSE) insider schedules sale of 3,374 shares; prior sale 42,594 - Stock Titan
SNSE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sensei Biotherapeutics Acquires Faeth Therapeutics and Raises US$200 Million in Private Placement - Global Legal Chronicle
Sensei Biotherapeutics Merges with Faeth Therapeutics, Secures $200M Funding - National Today
What is Sensei Biotherapeutics Inc. s revenue forecastJuly 2025 Trade Ideas & Precise Buy Zone Tips - mfd.ru
Sensei Biotherapeutics, Inc. (SNSE) Faeth Therapeutics, Inc.M&A CallSlideshow (NASDAQ:SNSE) 2026-02-20 - Seeking Alpha
Sensei Biotherapeutics (SNSE) COO and director added as SEC insider - Stock Titan
Sensei Biotherapeutics Acquires Faeth Therapeutics - Global Legal Chronicle
Sensei Biotherapeutics Closes Faeth Acquisition and Financing - The Globe and Mail
Sensei Biotherapeutics Secures Future with Faeth Therapeutics Acquisition and $200M Financing - Beijing Times
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition - MSN
Sensei Biotherapeutics Acquires Faeth Therapeutics and Secures $200 Million Funding - El-Balad.com
Sensei Biotherapeutics PIPE in Connection with its Acquisition of Faeth Therapeutics - Leerink Partners
Sensei/Faeth Merger Will Keep Both Firms’ Cancer Pipelines Active - Citeline News & Insights
Merger deal renews Faeth in Sensei; Piktor brightens, stock jumps - BioWorld MedTech
Small Cap Stocks To Add to Your WatchlistFebruary 18th - MarketBeat
Sensei Biotherapeutics Stock Soars 230% After Faeth Deal - Bitget
Why Is Sensei Biotherapeutics Stock Skyrocketing Wednesday?Sensei Biotherapeutics (NASDAQ:SNSE) - Benzinga
Sensei Biotherapeutics (SNSE) Shares Soar After $200M Acquisitio - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance - HIT Consultant
Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug - Fierce Biotech
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Jumps 150% On Faeth Therapeutics Buyout And $200M Financing - Nasdaq
Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition By Investing.com - Investing.com Canada
Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition - Investing.com
SNSE: Acquisition and $200M financing position the combined entity as a leader in multi-node cancer therapies - TradingView
Sensei Biotherapeutics (SNSE) Acquires Faeth Therapeutics to Exp - GuruFocus
SNSE: Acquisition and $200M financing advance a novel cancer therapy toward key clinical milestones - TradingView
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - The Joplin Globe
Form 4: Donenberg Phillip B. reports acquisition/exercise transactions in SNSE - Stock Titan
SNSE Technical Analysis & ETF Price Forecast - Intellectia AI
Sensei Biotherapeutics Expands Board, Adds Finance Expertise - The Globe and Mail
What is the Moat Score of Sensei Biotherapeutics Inc.Earnings Risk Summary & Weekly High Return Stock Forecasts - mfd.ru
Sensei Biotherapeutics Charts a Strategic Pivot After Halting Lead Candidate - AD HOC NEWS
Is Sensei Biotherapeutics Inc. stock a top performer YTDJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - mfd.ru
Is Sensei Biotherapeutics Inc.’s growth already priced inPortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru
Can Sensei Biotherapeutics Inc. be the next market leaderJuly 2025 Sector Moves & Weekly Setup with ROI Potential - mfd.ru
What is Sensei Biotherapeutics Incs TAM Total Addressable MarketDay Trade & Scalable Portfolio Growth Methods - baoquankhu1.vn
Market Rankings: Is Sensei Biotherapeutics Inc. a speculative investmentTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
AI Stocks: What is Sensei Biotherapeutics Incs revenue forecastProfit Target & Safe Capital Allocation Plans - baoquankhu1.vn
Sensei Biotherapeutics Halts Flagship Program, Weighs Sale or Shutdown - AD HOC NEWS
Portfolio Recap: Does Sensei Biotherapeutics Inc have pricing powerDay Trade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Valuation Update: Will FG Merger II Corp Equity Right outperform its industry peersNew Guidance & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Treasury Yields: Will Sensei Biotherapeutics Inc benefit from rising consumer demandMarket Volume Summary & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Sensei Biotherapeutics Shares Experience Turbulent Week’s End - AD HOC NEWS
Can Sensei Biotherapeutics Inc. stock rebound after recent weaknessEarnings Miss & Weekly High Potential Stock Alerts - bollywoodhelpline.com
Investor Mood: Whats the MACD signal for Sensei Biotherapeutics Inc2025 Support & Resistance & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Death Cross: What is the Moat Score of Sensei Biotherapeutics IncM&A Rumor & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):